Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2000
12/21/2000WO2000076988A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000WO2000076987A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076984A2 Novel compounds, their use and preparation
12/21/2000WO2000076981A1 Piperidinyl and piperazinyl substituted benzofused lactams
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076967A1 Benzylpiperazinyl-indolinylethanones
12/21/2000WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076532A1 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076506A1 Pharmaceutical formulations and methods comprising intranasal morphine
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076318A1 Nitric oxide donors for inducing neurogenesis
12/21/2000WO2000076314A1 Compositions and methods comprising morphine gluconate
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000056404B1 Formulations for treatment of pain comprising vitamin b12 and phenylanine
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000050014A3 Phenytoin sodium pharmaceutical compositions
12/21/2000WO2000048621A3 Methods and compositions for regulating protein-protein interactions
12/21/2000WO2000047762A3 Enriched central nervous system cell populations
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000044361A3 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
12/21/2000EP1144671A3 Enriched central nervous system cell populations
12/21/2000DE19927688A1 Multi-layered tablet containing tramadole and diclofenac, useful for treating pain, has separating layer between active ingredient layers
12/21/2000DE19925739A1 Therapeutikum mit einem Botulinum-Neurotoxin Agent with a botulinum neurotoxin
12/21/2000CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2376865A1 Compositions and methods comprising morphine gluconate
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376693A1 Immunological control of .beta.-amyloid levels in vivo
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376479A1 Retro-inverso peptides derived from interleukin-6
12/21/2000CA2376474A1 Retro-inverso peptides derived from leukemia inhibitory factor
12/21/2000CA2376432A1 Novel protein and dna thereof
12/21/2000CA2376420A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/21/2000CA2376394A1 Retro-inverso peptides derived from interleukin-3
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376357A1 .mu.o-conopeptides and their use as local anesthetics
12/21/2000CA2375851A1 1-azatricyclic-4-benzylpiperazines
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374616A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060242A1 Purified populations of stem cells
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060178A1 Heterocyclic compounds as inhibitors of rotamase enzymes
12/20/2000EP1060169A1 1,4-diazacycloheptane derivatives
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1059940A2 Method for treating painful conditions of the anal region and compositions therefor
12/20/2000EP1059930A1 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP1059925A1 Ep2-receptor agonists as neuroprotective agents for the eye
12/20/2000EP1059923A1 Combination of a selective nmda nr2b antagonist and an opioid analgesic
12/20/2000EP1059922A2 Glycine transport inhibitors
12/20/2000EP1059916A1 Extended release dosage form
12/20/2000EP1059889A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0801642B1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
12/20/2000EP0726898B1 Phenylindole compounds
12/20/2000EP0700378B1 Compounds which release nitric oxide
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
12/20/2000CN1277607A 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5-HT1b and 5-HT1D)
12/20/2000CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/20/2000CN1277555A Composition for improving mental capabilities in mammals
12/20/2000CN1277194A New 1- aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them
12/20/2000CN1277192A New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them
12/20/2000CN1277028A Production process of compound Meilingzhihua health food series
12/20/2000CN1277019A Medicament for intensifing brain acetylcholine releasing
12/20/2000CN1059583C Chinese herbal medicine oral liquid for deficiency syndrome
12/20/2000CN1059582C Traditional Chinese patent drug with function of intensifying intelligence and prolonging life
12/20/2000CN1059580C Sikang yangsheng health-care tablet
12/20/2000CN1059571C Medicinal capsule for replenishing vital essence and marrow beautifying and antisenility
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
1 ... 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 ... 1833